Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 6/20 | 0.33 |
| ▸ | THRA | P10827 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 2/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | RXRG | P48443 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4412722 | 0.81 | ALDH1A1 (0.35) | CYP3A4CYP2D6ALDH1A1CA2POLB | |
| SCHEMBL1905083 | 0.80 | CYP3A4 (0.32) | CYP3A4CYP2D6ALDH1A1CA2POLB | |
| SCHEMBL4413338 | 0.73 | CNR1 (0.33) | CYP3A4CYP2D6RXRARXRBRXRG | |
| SCHEMBL4887381 | 0.73 | CYP3A4 (0.31) | CYP3A4CYP2D6 | |
| SCHEMBL4889490 | 0.68 | CYP3A4 (0.34) | CYP3A4CYP2D6 | |
| SCHEMBL28234757 | 0.67 | THRA (0.39) | CYP3A4CYP2D6THRBTHRARXRA | |
| SCHEMBL5908087 | 0.67 | RXRA (0.47) | CYP3A4CYP2D6THRBTHRAALDH1A1 | |
| SCHEMBL17430868 | 0.66 | ESR1 (0.43) | ALDH1A1 | |
| SCHEMBL2914677 | 0.66 | CYP3A4 (0.36) | CYP3A4CYP2D6ALDH1A1CA2POLB | |
| SCHEMBL16994842 | 0.65 | MAPT (0.53) | CYP2D6THRBTHRAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615660-B2 | Production process of alkoxy-titanium complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-10 | — | — | US | disclosed |
| US-20080306293-A1 | Production Process of Alkoxy-Titanium Complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-12-11 | — | — | US | disclosed |
| EP-1845101-A1 | METHOD FOR PRODUCING ALKOXYTITANIUM COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2007-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306293-A1 | Production Process of Alkoxy-Titanium Complex | ABL1, H1-10, ALK | CYP3A4 165/4885CYP2D6 505/4885THRB 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.